Saturday, December 5, 2020
Financing and M&A

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing

The financing was led by Fidelity Management & Research Company LLC with additional support from new investors including GL Ventures (an affiliate of Hillhouse Capital), GIC, and a large, reputable long-term investor. Existing investors including Qiming Venture Partners and Boyu Capital also participated.

“We appreciate the recognition and trust from these prestigious investment institutions. This round of financing has drawn support from among the world’s largest asset managers, top-tier healthcare investors widely recognized in the capital markets, and strong continuous support from our existing investors. This is an important milestone to reinforce Antengene’s capabilities to bring cutting-edge therapies to help patients with life-threatening diseases in the Asia Pacific regions and around the world.” said Dr. Jay Mei, Founder, Chairman and CEO of Antengene.

Proceeds from the Series C financing will be primarily used to fund the continuing clinical development of Antengene’s robust pipeline of hematology and oncology therapies, expanding in-house research and development capabilities and strengthening the commercial infrastructures in APAC markets. To date, Antengene has made significant progress with its broad pipeline of six clinical-stage programs and six pre-clinical stage oncology assets:

  • ATG-010 (selinexor) is the first and only oral selective inhibitor of nuclear export (SINE) compound in the world. In July 2019, the U.S. FDA approved selinexor in combination with low-dose dexamethasone for the treatment of adult patients with relapsed/refractory multiple myeloma (RRMM). In June 2020, selinexor was approved by the U.S. FDA as a treatment for patients with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL). Currently, the registration clinical trials of ATG-010 in RRMM and R/R DLBCL are ongoing in China. The compound is also in late clinical development for various other hematologic malignancies and solid tumors (including KRAS mutant tumors). Pre-clinical studies demonstrated that inhibition of nuclear protein export through XPO1 can effectively treat tumors with such mutation.
  • ATG-008 (onatasertib) is a second-generation dual mTORC1/2 inhibitor presently studied in multi-regional clinical trials for the treatment of advanced hepatocellular carcinoma (HCC), as well as non-small-cell lung cancer (NSCLC), gynecological malignancies and other cancers as a single agent or in combination with an anti-PD-1 antibody.
  • ATG-016 (eltanexor) is a second-generation oral selective inhibitor of nuclear export protein XPO1 presently studied in myelodysplastic syndrome (MDS) as well as various types of solid tumors, such as colorectal cancer (CRC) and prostate cancer (PrC).
  • ATG-019 is a first-in-class PAK4/NAMPT dual-target inhibitor presently studied in a number of clinical trials including non-Hodgkin’s lymphoma (NHL), colorectal cancer, NSCLC, and melanoma. In addition, pre-clinical studies have demonstrated that ATG-019 in combination with anti-PD-1 antibodies can effectively improve the anti-tumor activity and is effective in treating patients that become resistant to anti-PD-1 therapy.
  • ATG-527 (verdinexor) is an innovative compound in clinical studies as a potential treatment for anti-viral infection and autoimmune diseases – such as Epstein-Barr virus (EBV), respiratory syncytial virus (RSV) infection, cytomegalovirus (CMV) infection, systemic lupus erythematosus (SLE). Phase I healthy volunteer study of the compound has been completed.
  • ATG-017 is a potent and selective small molecule extracellular signal–regulated kinases 1 and 2 (ERK1/2) inhibitor in clinical development for the treatment of various solid tumors, non-Hodgkin’s lymphoma, acute myeloid leukemia (AML) and multiple myeloma.

In addition, the Antengene drug discovery team is focused on the research and pre-clinical development of innovative small molecules, monoclonal and bi-specific antibodies to treat cancer. 

84 thoughts on “Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization
  1. Pingback: fun88
  2. Pingback: 4Change Energy
  3. Pingback: con tac ke so may
  4. I simply want to tell you that I am just new to blogs and really liked you’re page. Very likely I’m planning to bookmark your website . You actually have great well written articles. Regards for sharing your blog.

  5. A person essentially help to make seriously posts I would state. This is the first time I frequented your web page and thus far? I amazed with the research you made to create this particular publish amazing. Great job!

  6. Good info and right to the point. I don’t know if this is truly the best place to ask but do you folks have any ideea where to hire some professional writers? Thank you 🙂

  7. When I originally commented I clicked the -Notify me when new comments are added- checkbox and now each time a comment is added I get four emails with the identical comment. Is there any method you’ll be able to take away me from that service? Thanks!

  8. I simply want to say I am just new to blogs and really loved your web site. Very likely I’m going to bookmark your website . You surely come with really good posts. With thanks for sharing with us your website.

  9. Aw, this was a very nice post. In concept I would like to put in writing like this additionally – taking time and precise effort to make an excellent article… however what can I say… I procrastinate alot and by no means appear to get something done.

  10. Thank you for sharing superb informations. Your site is so cool. I’m impressed by the details that you’ve on this website. It reveals how nicely you understand this subject. Bookmarked this web page, will come back for more articles. You, my pal, ROCK! I found simply the information I already searched everywhere and just could not come across. What a perfect web-site.

  11. Pingback: buy youtube views
  12. It’s appropriate time to make some plans for the future and it’s time to be happy. I’ve read this post and if I could I desire to suggest you some interesting things or tips. Perhaps you could write next articles referring to this article. I want to read more things about it!

  13. I just want to mention I am just beginner to blogs and truly savored this web-site. Almost certainly I’m likely to bookmark your blog . You actually have terrific article content. Appreciate it for revealing your web site.

  14. I’m not that much of a online reader to be honest but your blogs really nice, keep it up! I’ll go ahead and bookmark your website to come back in the future. Many thanks

  15. Excellent blog you’ve got here.. It’s difficult to find high-quality writing like yours these days. I really appreciate individuals like you! Take care!!

  16. An added important area is that if you are an elderly person, travel insurance intended for pensioners is something you ought to really look at. The more aged you are, the more at risk you might be for allowing something awful happen to you while abroad. If you are not covered by several comprehensive insurance policies, you could have some serious issues. Thanks for expressing your guidelines on this weblog.

  17. An intriguing discussion is definitely worth comment. I think that you ought to write more about this issue, it might not be a taboo matter but typically folks don’t talk about these issues. To the next! Many thanks.

  18. Magnificent beat ! I wish to apprentice even as you amend your website, how can i subscribe for a weblog site? The account helped me a acceptable deal. I have been a little bit familiar of this your broadcast provided vivid transparent idea. buy cbd cbd oil for sale

  19. You really make it appear really easy along with your presentation however I find this matter to be really something which I feel I might by no means understand. It seems too complicated and very wide for me. I am having a look forward on your next publish, I¡¦ll attempt to get the hang of it!

  20. Excellent read, I just passed this onto a colleague who was doing some research on that. And he actually bought me lunch since I found it for him smile So let me rephrase that: Thanks for lunch!

  21. Everything is very open with a clear description of the challenges. It was really informative. Your site is very helpful. Many thanks for sharing!

  22. Hmm is anyone else experiencing problems with the pictures on this blog loading? I’m trying to find out if its a problem on my end or if it’s the blog. Any feed-back would be greatly appreciated.

  23. Hello! I merely want to give you a enormous thumbs up for that great information you might have here for this post. I am returning to your blog post to get more detailed soon.

  24. Everything is very open with a clear clarification of the issues. It was truly informative. Your site is extremely helpful. Many thanks for sharing!

  25. Right here is the right site for everyone who wants to understand this topic. You know so much its almost hard to argue with you (not that I actually will need to…HaHa). You definitely put a fresh spin on a topic that’s been discussed for decades. Wonderful stuff, just wonderful.

  26. What i do not realize is actually how you’re not really much more well-liked than you might be now. You are very intelligent. You realize thus considerably relating to this subject, produced me personally consider it from a lot of varied angles. Its like men and women aren’t fascinated unless it’s one thing to accomplish with Lady gaga! Your own stuffs nice. Always maintain it up!

  27. I¡¦ve been exploring for a little for any high quality articles or blog posts in this sort of house . Exploring in Yahoo I finally stumbled upon this site. Reading this information So i am satisfied to show that I have an incredibly just right uncanny feeling I came upon just what I needed. I so much certainly will make certain to do not overlook this site and give it a glance on a continuing basis.

  28. Good day! Do you know if they make any plugins to assist with Search Engine Optimization? I’m trying to get my blog to rank for some targeted keywords but I’m not seeing very good success. If you know of any please share. Cheers!

  29. Hi, you used to write excellent articles, but the last several posts have been kinda boring… I miss your super writing. Past several posts are just a little out of track!

  30. Hello there! I could have sworn I’ve been to this web site before but after browsing through many of the posts I realized it’s new to me. Regardless, I’m definitely delighted I came across it and I’ll be bookmarking it and checking back frequently!

  31. I would like to thank you for the efforts you’ve put in penning this website. I’m hoping to see the same high-grade blog posts by you in the future as well. In fact, your creative writing abilities has motivated me to get my own website now 😉

  32. Hello there! I could have sworn I’ve been to this blog before but after looking at many of the articles I realized it’s new to me. Nonetheless, I’m certainly delighted I came across it and I’ll be bookmarking it and checking back frequently!

  33. I must say, as a lot as I enjoyed reading what you had to say, I couldnt help but lose interest after a while. Its as if you had a wonderful grasp on the subject matter, but you forgot to include your readers. Perhaps you should think about this from far more than one angle. Or maybe you shouldnt generalise so considerably. Its better if you think about what others may have to say instead of just going for a gut reaction to the subject. Think about adjusting your own believed process and giving others who may read this the benefit of the doubt.Jobs offered

  34. hey there and thank you for your information – I have certainly picked up anything new from right here. I did however expertise a few technical points using this website, as I experienced to reload the website many times previous to I could get it to load properly. I had been wondering if your web host is OK? Not that I am complaining, but slow loading instances times will very frequently affect your placement in google and could damage your high quality score if advertising and marketing with Adwords. Anyway I am adding this RSS to my e-mail and could look out for a lot more of your respective intriguing content. Make sure you update this again very soon..

  35. Hello there! I just would like to offer you a big thumbs up for your excellent information you’ve got here on this post. I will be returning to your web site for more soon.

  36. Fantastic goods from you, man. I’ve take note your stuff prior to and you’re just extremely excellent. I actually like what you’ve obtained here, certainly like what you are saying and the way in which during which you assert it. You make it entertaining and you continue to care for to keep it sensible. I cant wait to learn much more from you. That is really a wonderful site.

  37. Nice post. I learn something new and challenging on websites I stumbleupon on a daily basis. It will always be useful to read through articles from other authors and practice a little something from other sites.

  38. After looking at a handful of the blog articles on your website, I honestly like your technique of writing a blog. I bookmarked it to my bookmark website list and will be checking back in the near future. Take a look at my website as well and tell me your opinion.

Leave a Reply

Your email address will not be published.